0.5057.34% ( -0.040 )
Delay Closed: Nov 17, 16:08:00Valuation
Current ValuationThe current P/E ratio is 14.05, within the reasonable range, cheaper than 33.67% of the time in the past 5 years, and the industry ranks 4/15, the industry Median 12.44.
14.05xP/E
HK$0.55Stock price
HK$0.04Earnings per share
14.05xP/E
Stock priceHK$0.55Earnings per shareHK$0.04
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 10.21x
- Typical range
- -3.19x–20.37x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.44x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.44x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
06127HKJOINN | 12.44x | 241.61% | HK$16.62B |
03880HKMedtide Inc. | 13.71x | -- | HK$2.67B |
01873HKVIVA BIOTECH | 12.41x | -- | HK$2.54B |
06118HKAUSTAR | 14.05x | -- | HK$279.36M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
